{"transactions":[{"id":776803,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T23:48:25.000Z","date":"2026-05-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-227500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000119312526227500/ownership.xml","form_type":"4"}},{"id":1145008,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T20:30:30.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan."}],"balance_after":32000,"derivative":{"underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000950170-25-073606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000095017025073606/ownership.xml","form_type":"4"}},{"id":1478694,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-14T20:10:05.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) and (ii) the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.31,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-073647","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000095017024073647/ownership.xml","form_type":"4"}},{"id":1835447,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-07-06T01:52:34.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on June 30, 2024, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.11,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-23-031872","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000095017023031872/ownership.xml","form_type":"4"}},{"id":1989892,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-27T21:05:27.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":36000,"derivative":{"underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0000899243-23-006207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924323006207/doc4.xml","form_type":"4"}},{"id":1989891,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-27T21:05:27.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":213000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023."}],"balance_after":213000,"derivative":{"exercise_price":1.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":213000},"source":{"system":"sec-edgar","filing":"0000899243-23-006207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924323006207/doc4.xml","form_type":"4"}},{"id":2056342,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-11T21:05:27.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":3729,"price":1.3912,"value":5187.7848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.39 to $1.41. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2."}],"balance_after":14219,"source":{"system":"sec-edgar","filing":"0000899243-23-001576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924323001576/doc4.xml","form_type":"4"}},{"id":2066283,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T21:34:11.000Z","date":"2023-01-01","kind":"exercise","acquired":false,"shares":6930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date."}],"balance_after":14070,"derivative":{"underlying":"Common Stock","underlying_shares":6930},"source":{"system":"sec-edgar","filing":"0000899243-23-000626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924323000626/doc4.xml","form_type":"4"}},{"id":2066282,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T21:34:11.000Z","date":"2023-01-01","kind":"exercise","acquired":false,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date."}],"balance_after":6800,"derivative":{"underlying":"Common Stock","underlying_shares":6600},"source":{"system":"sec-edgar","filing":"0000899243-23-000626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924323000626/doc4.xml","form_type":"4"}},{"id":2066281,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-04T21:34:11.000Z","date":"2023-01-01","kind":"exercise","acquired":true,"shares":6930,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":17948,"source":{"system":"sec-edgar","filing":"0000899243-23-000626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924323000626/doc4.xml","form_type":"4"}},{"id":2066280,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-04T21:34:11.000Z","date":"2023-01-01","kind":"exercise","acquired":true,"shares":6600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":11018,"source":{"system":"sec-edgar","filing":"0000899243-23-000626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924323000626/doc4.xml","form_type":"4"}},{"id":2225119,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-21T20:06:14.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on the earlier of (i) June 16, 2023 (the one-year anniversary of the date of grant) and (ii) the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":7250,"derivative":{"exercise_price":5.09,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0000899243-22-023339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924322023339/doc4.xml","form_type":"4"}},{"id":2368539,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2022-02-28T21:06:10.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.  The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.  The restricted stock units have no expiration date."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-22-008064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924322008064/doc4.xml","form_type":"4"}},{"id":2368538,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-28T21:06:10.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022."}],"balance_after":126000,"derivative":{"exercise_price":2.71,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":126000},"source":{"system":"sec-edgar","filing":"0000899243-22-008064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924322008064/doc4.xml","form_type":"4"}},{"id":2436568,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2022-01-12T21:05:47.000Z","date":"2022-01-01","kind":"exercise","acquired":false,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.  The RSUs do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.  The RSUs do not have an expiration date."}],"balance_after":13400,"derivative":{"underlying":"Common Stock","underlying_shares":6600},"source":{"system":"sec-edgar","filing":"0000899243-22-001749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924322001749/doc4.xml","form_type":"4"}},{"id":2436567,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2022-01-12T21:05:47.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":2182,"price":3.7802,"value":8248.3964,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.80.  The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3."}],"balance_after":4418,"source":{"system":"sec-edgar","filing":"0000899243-22-001749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924322001749/doc4.xml","form_type":"4"}},{"id":2436566,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2022-01-12T21:05:47.000Z","date":"2022-01-01","kind":"exercise","acquired":true,"shares":6600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":6600,"source":{"system":"sec-edgar","filing":"0000899243-22-001749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924322001749/doc4.xml","form_type":"4"}},{"id":2690936,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-05-28T22:23:28.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on the earlier of (i) May 26, 2022 (the one-year anniversary of the date of grant) and (ii) the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date."}],"balance_after":7250,"derivative":{"exercise_price":7.24,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0000899243-21-021185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924321021185/doc4.xml","form_type":"4"}},{"id":2871423,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-09T21:22:52.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":101904,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000899243-21-005458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924321005458/doc4.xml","form_type":"4"}},{"id":2871422,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2021-02-09T21:22:52.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-005458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924321005458/doc4.xml","form_type":"4"}},{"id":2871421,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-09T21:22:52.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":122000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021."}],"balance_after":122000,"derivative":{"exercise_price":13.78,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":122000},"source":{"system":"sec-edgar","filing":"0000899243-21-005458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924321005458/doc4.xml","form_type":"4"}},{"id":2871420,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2021-02-09T21:22:52.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":13500,"price":14.2537,"value":192424.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $14.00 to $14.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-005458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924321005458/doc4.xml","form_type":"4"}},{"id":2871419,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2021-02-09T21:22:52.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":13500,"price":0.64,"value":8640.0,"ownership":{"direct":true},"balance_after":13500,"source":{"system":"sec-edgar","filing":"0000899243-21-005458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924321005458/doc4.xml","form_type":"4"}},{"id":3288336,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2020-02-05T21:06:09.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":103404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-20-003248","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924320003248/doc4.xml","form_type":"4"}},{"id":3288335,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2020-02-05T21:06:09.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":12000,"price":16.1555,"value":193866.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold in multiple transactions at per share prices ranging from $16.0300 to $16.3400.  The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-003248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924320003248/doc4.xml","form_type":"4"}},{"id":3288334,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2020-02-05T21:06:09.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":12000,"price":0.6316,"value":7579.2,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000899243-20-003248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924320003248/doc4.xml","form_type":"4"}},{"id":3322060,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2020-01-03T22:32:40.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":115404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-20-000313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924320000313/doc4.xml","form_type":"4"}},{"id":3322059,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2020-01-03T22:32:40.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":6000,"price":20.4974,"value":122984.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold in multiple transactions at per share prices ranging from $20.4200 to $20.6500.  The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-000313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924320000313/doc4.xml","form_type":"4"}},{"id":3322058,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2020-01-03T22:32:40.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":6000,"price":0.6316,"value":3789.6,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-20-000313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924320000313/doc4.xml","form_type":"4"}},{"id":3342147,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-13T21:05:34.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2020."}],"balance_after":111000,"derivative":{"exercise_price":19.92,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":111000},"source":{"system":"sec-edgar","filing":"0000899243-19-029153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319029153/doc4.xml","form_type":"4"}},{"id":3353829,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2019-12-03T21:07:18.000Z","date":"2019-12-02","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":121404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-028395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319028395/doc4.xml","form_type":"4"}},{"id":3353828,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2019-12-03T21:07:18.000Z","date":"2019-11-29","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":127404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-028395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319028395/doc4.xml","form_type":"4"}},{"id":3353827,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-12-03T21:07:18.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":6000,"price":16.211,"value":97266.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold in multiple transactions at per share prices ranging from $16.03 to $16.35.  The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319028395/doc4.xml","form_type":"4"}},{"id":3353826,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-12-03T21:07:18.000Z","date":"2019-12-02","kind":"exercise","acquired":true,"shares":6000,"price":0.64,"value":3840.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-19-028395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319028395/doc4.xml","form_type":"4"}},{"id":3353825,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-12-03T21:07:18.000Z","date":"2019-11-29","kind":"sale","acquired":false,"shares":6000,"price":16,"value":96000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-028395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319028395/doc4.xml","form_type":"4"}},{"id":3353824,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-12-03T21:07:18.000Z","date":"2019-11-29","kind":"exercise","acquired":true,"shares":6000,"price":0.64,"value":3840.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-19-028395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319028395/doc4.xml","form_type":"4"}},{"id":3400555,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2019-10-02T20:08:49.000Z","date":"2019-10-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":133404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-024658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319024658/doc4.xml","form_type":"4"}},{"id":3400554,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-10-02T20:08:49.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":100,"price":18.23,"value":1823.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-024658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319024658/doc4.xml","form_type":"4"}},{"id":3400553,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-10-02T20:08:49.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":5900,"price":17.3803,"value":102543.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $17.10 to $17.85. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000899243-19-024658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319024658/doc4.xml","form_type":"4"}},{"id":3400552,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-10-02T20:08:49.000Z","date":"2019-10-01","kind":"exercise","acquired":true,"shares":6000,"price":0.64,"value":3840.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-19-024658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319024658/doc4.xml","form_type":"4"}},{"id":3421556,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2019-09-05T20:42:30.000Z","date":"2019-09-03","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":139404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-022841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319022841/doc4.xml","form_type":"4"}},{"id":3421555,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-09-05T20:42:30.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":6000,"price":18.7365,"value":112419.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $18.36 to $19.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-022841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319022841/doc4.xml","form_type":"4"}},{"id":3421554,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-09-05T20:42:30.000Z","date":"2019-09-03","kind":"exercise","acquired":true,"shares":6000,"price":0.64,"value":3840.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-19-022841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319022841/doc4.xml","form_type":"4"}},{"id":3446743,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2019-08-05T20:16:50.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":145404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-020992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319020992/doc4.xml","form_type":"4"}},{"id":3446742,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-08-05T20:16:50.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":6000,"price":17.3651,"value":104190.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $16.73 to $17.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-020992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319020992/doc4.xml","form_type":"4"}},{"id":3446741,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-08-05T20:16:50.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":6000,"price":0.64,"value":3840.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-19-020992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319020992/doc4.xml","form_type":"4"}},{"id":3467566,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2019-07-03T20:30:27.000Z","date":"2019-07-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":151404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-019175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319019175/doc4.xml","form_type":"4"}},{"id":3467565,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-07-03T20:30:27.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":6000,"price":18.9952,"value":113971.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $18.53 to $19.48. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-019175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319019175/doc4.xml","form_type":"4"}},{"id":3467564,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-07-03T20:30:27.000Z","date":"2019-07-01","kind":"exercise","acquired":true,"shares":6000,"price":0.64,"value":3840.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-19-019175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319019175/doc4.xml","form_type":"4"}},{"id":3500209,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee Stock Option","published_at":"2019-06-05T22:16:25.000Z","date":"2019-06-03","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017."}],"balance_after":157404,"derivative":{"exercise_price":0.64,"expiration_date":"2027-04-05","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-19-015653","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319015653/doc4.xml","form_type":"4"}},{"id":3500208,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-06-05T22:16:25.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":6000,"price":19.944,"value":119664.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold in multiple transactions at per share prices ranging from $19.46 to $20.42.  The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-015653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319015653/doc4.xml","form_type":"4"}},{"id":3500207,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Common Stock","published_at":"2019-06-05T22:16:25.000Z","date":"2019-06-03","kind":"exercise","acquired":true,"shares":6000,"price":0.64,"value":3840.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-19-015653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924319015653/doc4.xml","form_type":"4"}},{"id":3726428,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee stock option","published_at":"2018-12-18T22:20:28.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2019."}],"balance_after":88000,"derivative":{"exercise_price":24.28,"expiration_date":"2028-12-14","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0000899243-18-031340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924318031340/doc4.xml","form_type":"4"}},{"id":3979492,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Treasurer & Secretary"}}],"security":"Employee stock option","published_at":"2018-03-29T22:47:14.000Z","date":"2018-03-27","kind":"grant","acquired":true,"shares":49711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal monthly installments on the first day of each calendar month following March 27, 2018."}],"balance_after":49711,"derivative":{"exercise_price":16,"expiration_date":"2028-03-27","underlying":"Common Stock","underlying_shares":49711},"source":{"system":"sec-edgar","filing":"0000899243-18-008914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924318008914/doc4.xml","form_type":"4"}},{"id":4456877,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":46838,"kind":"person","name":"Smith W Bradford","position":1,"cik":"0001317678","reported_name":"Smith W Bradford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-10T21:29:59.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":90000,"derivative":{"exercise_price":6.56,"expiration_date":"2027-01-30","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000899243-17-003482","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1317678/000089924317003482/doc4.xml","form_type":"4"}}]}